Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism

被引:23
作者
Bash-Imam, Zeina [1 ]
Therizols, Gabriel [1 ]
Vincent, Anne [1 ]
Laforets, Florian [1 ]
Espinoza, Micaela Polay [1 ]
Pion, Nathalie [1 ]
Macari, Francoise [4 ]
Pannequin, Julie [4 ]
David, Alexandre [4 ]
Saurin, Jean-Christophe [1 ]
Mertani, Hichem C. [1 ]
Textoris, Julien [3 ]
Auboeuf, Didier [1 ]
Catez, Frederic [1 ]
Venezia, Nicole Dalla [1 ]
Dutertre, Martin [2 ]
Marcel, Virginie [1 ]
Diaz, Jean-Jacques [1 ]
机构
[1] Univ Lyon 1, INSERM 1052, CNRS 5286, Ctr Leon Berard,Ctr Rech Cancerol Lyon, F-69373 Lyon, France
[2] Ctr Univ Orsay, CNRS UMR 3348, Inst Curie, F-91405 Orsay, France
[3] Univ Lyon 1, Hosp Civils Lyon, bioMerieux SA Pathophysiol Injury Induced Immunos, EA7426, F-69003 Lyon, France
[4] Univ Montpellier, INSERM, CNRS, IGF, F-34094 Montpellier, France
关键词
5-fluorouracil; translation; translatome profiling; miRNA; colorectal cancer; RNA METHYLATION; GENE; IDENTIFICATION; CYTOTOXICITY; FLUOROURACIL; INHIBITION; APOPTOSIS; TARGETS; DNA;
D O I
10.18632/oncotarget.17597
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5-fluorouracil (5-FU) is a widely used chemotherapeutic drug in colorectal cancer. Previous studies showed that 5-FU modulates RNA metabolism and mRNA expression. In addition, it has been reported that 5-FU incorporates into the RNAs constituting the translational machinery and that 5-FU affects the amount of some mRNAs associated with ribosomes. However, the impact of 5-FU on translational regulation remains unclear. Using translatome profiling, we report that a clinically relevant dose of 5-FU induces a translational reprogramming in colorectal cancer cell lines. Comparison of mRNA distribution between polysomal and non-polysomal fractions in response to 5-FU treatment using microarray quantification identified 313 genes whose translation was selectively regulated. These regulations were mostly stimulatory (91%). Among these genes, we showed that 5-FU increases the mRNA translation of HIVEP2, which encodes a transcription factor whose translation in normal condition is known to be inhibited by mir-155. In response to 5-FU, the expression of mir-155 decreases thus stimulating the translation of HIVEP2 mRNA. Interestingly, the 5-FU-induced increase in specific mRNA translation was associated with reduction of global protein synthesis. Altogether, these findings indicate that 5-FU promotes a translational reprogramming leading to the increased translation of a subset of mRNAs that involves at least for some of them, miRNA-dependent mechanisms. This study supports a still poorly evaluated role of translational control in drug response.
引用
收藏
页码:46219 / 46233
页数:15
相关论文
共 50 条
  • [31] The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
    Jover, Rodrigo
    Zapater, Pedro
    Castells, Antoni
    Llord, Xavier
    Andreu, Montserrat
    Cubiella, Joaquin
    Balaguer, Francesc
    Sempere, Laura
    Xicola, Rosa M.
    Bujanda, Luis
    Rene, Josep M.
    Clofent, Juan
    Bessa, Xavier
    Morillas, Juan D.
    Nicolas-Perez, David
    Pons, Elisenda
    Paya, Artemio
    Alenda, Cristina
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (03) : 365 - 373
  • [32] Differential effects of 5-fluorouracil and oxaliplatin on autophagy in chemoresistant colorectal cancer cells
    Zitkute, Vilmante
    Kukcinaviciute, Egle
    Jonusiene, Violeta
    Starkuviene, Vytaute
    Sasnauskiene, Ausra
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (06) : 1103 - 1115
  • [33] Diosmetin Exerts Synergistic Effects in Combination with 5-Fluorouracil in Colorectal Cancer Cells
    Kamran, Sareh
    Sinniah, Ajantha
    Chik, Zamri
    Alshawsh, Mohammed Abdullah
    BIOMEDICINES, 2022, 10 (03)
  • [34] Beyond 5-fluorouracil monochemotherapy in colorectal cancer - It is time
    Satta, F
    Franchi, F
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 431 - 435
  • [35] Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer
    Matsusaka, Satoshi
    Yamasaki, Hajime
    Fukushima, Masakazu
    Wakabayashi, Ichiro
    CHEMOTHERAPY, 2007, 53 (01) : 36 - 41
  • [36] Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells
    Shi, Zhong
    Bai, Rui
    Fu, Zhi-xuan
    Zhu, Yong-liang
    Wang, Rong-fu
    Zheng, Shu
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2012, 13 (01): : 11 - 19
  • [37] 5-FLUOROURACIL MODULATION IN THE CHEMOTHERAPY OF COLORECTAL-CANCER
    CODACCIPISANELLI, G
    FRANCHI, F
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1994, 26 (07): : 369 - 376
  • [38] Functional mechanism of the enhancement of 5-fluorouracil sensitivity by TUSC4 in colon cancer cells
    Liu, Ming-Na
    Liu, Ai-Yun
    Pei, Feng-Hua
    Ma, Xiao
    Fan, Yu-Jing
    Du, Ya-Ju
    Liu, Bing-Rong
    ONCOLOGY LETTERS, 2015, 10 (06) : 3682 - 3688
  • [39] Dihydroartemisinin potentiates antitumor activity of 5-fluorouracil against a resistant colorectal cancer cell line
    Yao, Zhihan
    Bhandari, Adheesh
    Wang, Yinghao
    Pan, Yiyuan
    Yang, Fan
    Chen, Rongfa
    Xia, Erjie
    Wang, Ouchen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 501 (03) : 636 - 642
  • [40] Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells
    Yong Cao
    Yan Lin
    Dongxu Wang
    Di Pan
    Ying Zhang
    Yu Jin
    Changqing Zheng
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 1081 - 1086